PHVS
Price:
$27.69
Market Cap:
$1.54B
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Neth...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
PHVS
According to Pharvaris N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.34B. This represents a change of 116.10% compared to the average of 622.04M of the last 4 quarters.
The mean historical Enterprise Value of Pharvaris N.V. over the last ten years is 486.77M. The current 1.34B Enterprise Value has changed 27.51% with respect to the historical average. Over the past ten years (40 quarters), PHVS's Enterprise Value was at its highest in in the December 2023 quarter at 935.97M. The Enterprise Value was at its lowest in in the March 2017 quarter at -1198783.00.
Average
486.77M
Median
604.39M
Minimum
-4795135.00
Maximum
803.03M
Discovering the peaks and valleys of Pharvaris N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.62%
Maximum Annual Enterprise Value = 803.03M
Minimum Annual Increase = -16778.97%
Minimum Annual Enterprise Value = -4795135.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 720.18M | 23.48% |
| 2023 | 583.25M | 204.62% |
| 2022 | 191.47M | 8.94% |
| 2021 | 175.75M | -71.90% |
| 2020 | 625.53M | -22.10% |
| 2019 | 803.03M | 0.41% |
| 2018 | 799.78M | -16778.97% |
The current Enterprise Value of Pharvaris N.V. (PHVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
498.30M
5-year avg
459.23M
10-year avg
486.77M
Pharvaris N.V.’s Enterprise Value is less than Immunome, Inc. (1.70B), less than Spyre Therapeutics, Inc. (1.96B), greater than Intellia Therapeutics, Inc. (925.20M), less than Maze Therapeutics, Inc. (1.76B), less than Upstream Bio, Inc. (1.46B), greater than Zymeworks Inc. (-43935349065.00), less than BioCryst Pharmaceuticals, Inc. (2.30B), less than Vera Therapeutics, Inc. (2.75B), greater than ORIC Pharmaceuticals, Inc. (1.06B), less than Ardelyx, Inc. (1.58B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.70B | $1.84B | |
| 1.96B | $2.02B | |
| 925.20M | $1.02B | |
| 1.76B | $2.05B | |
| 1.46B | $1.50B | |
| -43935349065.00 | $1.99B | |
| 2.30B | $1.65B | |
| 2.75B | $2.72B | |
| 1.06B | $1.11B | |
| 1.58B | $1.42B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharvaris N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharvaris N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharvaris N.V.'s Enterprise Value?
What is the highest Enterprise Value for Pharvaris N.V. (PHVS)?
What is the 3-year average Enterprise Value for Pharvaris N.V. (PHVS)?
What is the 5-year average Enterprise Value for Pharvaris N.V. (PHVS)?
How does the current Enterprise Value for Pharvaris N.V. (PHVS) compare to its historical average?